FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

4789911000001103: Tractocile 37.5mg/5ml solution for injection vials (Ferring Pharmaceuticals Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
18410701000001118 Tractocile 37.5mg/5ml solution for injection vials (Ferring Pharmaceuticals Ltd) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
52478301000001114 Tractocile 37.5mg/5ml solution for infusion vials (Ferring Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Tractocile 37.5mg/5ml solution for injection vials (Ferring Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Tractocile 37.5mg/5ml solution for injection vials (Ferring Pharmaceuticals Ltd) Is a Atosiban 7.5mg/mL infusion concentrate 5mL vial false Inferred relationship Existential restriction modifier
Tractocile 37.5mg/5ml solution for injection vials (Ferring Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Tractocile 37.5mg/5ml solution for injection vials (Ferring Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Tractocile 37.5mg/5ml solution for injection vials (Ferring Pharmaceuticals Ltd) Has active ingredient Atosiban true Inferred relationship Existential restriction modifier
Tractocile 37.5mg/5ml solution for injection vials (Ferring Pharmaceuticals Ltd) Has active ingredient Atosiban acetate false Inferred relationship Existential restriction modifier
Tractocile 37.5mg/5ml solution for injection vials (Ferring Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Tractocile 37.5mg/5ml solution for injection vials (Ferring Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Tractocile 37.5mg/5ml solution for injection vials (Ferring Pharmaceuticals Ltd) Has active ingredient Atosiban acetate false Inferred relationship Existential restriction modifier
Tractocile 37.5mg/5ml solution for injection vials (Ferring Pharmaceuticals Ltd) Has manufactured dose form Conventional release solution for injection false Inferred relationship Existential restriction modifier
Tractocile 37.5mg/5ml solution for injection vials (Ferring Pharmaceuticals Ltd) Is a Tractocile true Inferred relationship Existential restriction modifier
Tractocile 37.5mg/5ml solution for injection vials (Ferring Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Atosiban true Inferred relationship Existential restriction modifier
Tractocile 37.5mg/5ml solution for injection vials (Ferring Pharmaceuticals Ltd) Has specific active ingredient Atosiban acetate true Inferred relationship Existential restriction modifier
Tractocile 37.5mg/5ml solution for injection vials (Ferring Pharmaceuticals Ltd) Has dispensed dose form Conventional release solution for infusion true Inferred relationship Existential restriction modifier
Tractocile 37.5mg/5ml solution for injection vials (Ferring Pharmaceuticals Ltd) Has manufactured dose form Injection false Inferred relationship Existential restriction modifier
Tractocile 37.5mg/5ml solution for injection vials (Ferring Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Tractocile 37.5mg/5ml solution for injection vials (Ferring Pharmaceuticals Ltd) Has basis of strength substance Atosiban true Inferred relationship Existential restriction modifier
Tractocile 37.5mg/5ml solution for injection vials (Ferring Pharmaceuticals Ltd) Is a Atosiban 37.5mg/5ml solution for infusion vials false Inferred relationship Existential restriction modifier
Tractocile 37.5mg/5ml solution for injection vials (Ferring Pharmaceuticals Ltd) Is a Atosiban 37.5mg/5ml solution for infusion vials true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Tractocile 37.5mg/5ml solution for injection vials (Ferring Pharmaceuticals Ltd) 1 vial Is pack of False Tractocile 37.5mg/5ml solution for injection vials (Ferring Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Tractocile 37.5mg/5ml solution for injection vials (Ferring Pharmaceuticals Ltd) 1 vial Has AMP True Tractocile 37.5mg/5ml solution for injection vials (Ferring Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start